GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rock Creek Pharmaceuticals Inc (OTCPK:RCPIQ) » Definitions » Treasury Stock

Rock Creek Pharmaceuticals (Rock Creek Pharmaceuticals) Treasury Stock : $0.00 Mil (As of Jun. 2016)


View and export this data going back to 2015. Start your Free Trial

What is Rock Creek Pharmaceuticals Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Rock Creek Pharmaceuticals's treasury stock for the quarter that ended in Jun. 2016 was $0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.


Rock Creek Pharmaceuticals Treasury Stock Historical Data

The historical data trend for Rock Creek Pharmaceuticals's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rock Creek Pharmaceuticals Treasury Stock Chart

Rock Creek Pharmaceuticals Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Treasury Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Rock Creek Pharmaceuticals Quarterly Data
Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16
Treasury Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Rock Creek Pharmaceuticals Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.


Rock Creek Pharmaceuticals (Rock Creek Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
2040 Whitfield Avenue, Suite 300, Sarasota, FL, USA, 34243
Rock Creek Pharmaceuticals Inc is engaged in research, development, and commercialization of therapies for chronic inflammatory disease and neurologic disorders, utilizing its proprietary compounds. The company is focusing its drug development efforts on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its proprietary formulations of its lead compound anatabine citrate. Its objective is to develop, obtain approval for, and commercialize pharmaceutical products utilizing its anatabine-based and related compounds.
Executives
Lee M Canaan director 20101 HOOVER RD, DETROIT MI 48205
Naomi Whittel director C/O STAR SCIENTIFIC, INC., 4470 COX ROAD, SUITE 110, GLEN ALLEN VA 23060
Ralph B Everett director 1299 PENNSYLVANIA AVE NW, 10TH FL, WASHINGTON DC 20004-2400
Richard L Sharp director C/O CIRCUIT CITY STORES, 9950 MAYLAND DRIVE, RICHMOND VA 23233
Marc D Oken director C/O FALFURRIAS CAPITAL PARTNERS, 100 N. TRYON STREET, SUITE 5120, CHARLOTTE NC 28202
Odonnell Kathleen M Tr Irrev Tr 1 Fbo Francis E Odonnell Jr other: former 10% owner
David C Vorhoff director C/O STAR SCIENTIFIC, INC., 801 LIBERTY WAY, CHESTER VA 23836
Christopher G Miller officer: Chief Financial Officer 801 LIBERTY WAY CHESTER VA 23836

Rock Creek Pharmaceuticals (Rock Creek Pharmaceuticals) Headlines

From GuruFocus

Star Scientific Inc. (STSI) President & COO Paul L Perito buys 20,000 Shares

By GuruFocus Research GuruFocus Editor 11-16-2009

Star Scientific Inc. (STSI) CFO Park A Iii Dodd buys 10,000 Shares

By GuruFocus Research GuruFocus Editor 11-18-2009

Star Scientific Inc. (STSI) President & COO Paul L Perito buys 30,000 Shares

By GuruFocus Research GuruFocus Editor 11-13-2009